The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment of aggressive prostate cancers in real life: Initiation, schedule, and management of triptorelin treatment (TALISMAN)—Design of the study.
 
Thierry Lebret
Honoraria - AstraZeneca; Bayer; Ipsen; Roche
Consulting or Advisory Role - Ipsen
 
Jerome Rigaud
Honoraria - Astellas Pharma; Ipsen; Janssen; Recordati; Takeda
Travel, Accommodations, Expenses - Ipsen
 
Gilles Crehange
Honoraria - Astellas Pharma; BD Bard; Ferring; Ipsen; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; BD Bard; Ferring; Ipsen; Janssen; Sanofi
 
Nathalie Pello Leprince Ringuet
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Anne-Sophie Grandoulier
Other Relationship - Ipsen (Inst)
 
Antoine Thiery-Vuillemin
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche; Sanofi
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Pfizer; Roche